Guideline-directed medical therapy (GDMT) for heart failure

DRUG2 trials

Conditions

Cardiovascular DiseasesChronic Heart FailureHeart FailureHeart Failure With Mid Range Ejection FractionHeart Failure With Preserved Ejection FractionHeart Failure With Reduced Ejection FractionHypertensionPulmonary Hypertension

Phase 3

A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure

Active, not recruitingNCT05824923

Pulnovo Medical (Wuxi) Co., Ltd.Cardiovascular Diseases, Heart Failure, Heart Failure With Mid Range Ejection Fraction +5

Start: 2023-08-14End: 2027-02-01Target: 264Updated: 2026-07-21

Unknown Phase

Vericiguat and Exercise Hemodynamics in Patients With HFrEF

CompletedNCT07697365

Argyrios NtalianisChronic Heart Failure, Heart Failure With Reduced Ejection Fraction

Start: 2024-01-31End: 2025-12-31Updated: 2026-07-13

New England Journal of Medicine2026-08-30

Pulmonary Artery Denervation for the Treatment of Patients With Pulmonary Hypertension Secondary to Left-Sided Heart Failure: Rationale and Design of the Randomized Controlled PADN-HF-PH Trial

Cardiology Discovery2026-01-08

Guideline-directed medical therapy (GDMT) for heart failure

Sponsors

Conditions

Phase 3

Unknown Phase

Related Papers